Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medipharm Labs Corp
T.LABS
Alternate Symbol(s):
MEDIF
Healthcare
Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,...
packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:LABS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(571)
•••
mdjbrown
X
View Profile
View Bullboard History
Comment by
mdjbrown
on Apr 06, 2024 12:10pm
RE:RE:Our competition and somewhat good news. MEDIF update us pls.
QC, I am not so sure some of these medical cannabis will be held up as long as traditional FDA medicine approvals, due to its infancy in medicine. Look no further than Epidiolex, which at the time
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Apr 06, 2024 12:10pm
RE:RE:RE:RE:Our competition and somewhat good news. MEDIF update us pls.
Nicely said mdj. It should be for all LABS investors at this point based on the information released by the company, it is NOT a matter of if but now only a matter of when and the when
...more
(571)
•••
mdjbrown
X
View Profile
View Bullboard History
Comment by
mdjbrown
on Apr 06, 2024 11:53am
RE:RE:RE:Our competition and somewhat good news. MEDIF update us pls.
Macpoor, if Medipharm shareholders were holding out hope for just one specific outcome, I agree it would be sad, but Labs has so many promising international irons in the fire, one home run will make
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Apr 06, 2024 11:01am
Mdjbrown...Apotex IS a an export doorway to China, NO DOUBT.
1997...therefore already well established in China but keep reading further below. Apotex, working with LABS could export generic Epidiolex to China and that market dwarfs the U.S. market.
...more
(73)
•••
Macpoor
X
View Profile
View Bullboard History
Comment by
Macpoor
on Apr 06, 2024 10:44am
RE:RE:Our competition and somewhat good news. MEDIF update us pls.
I agree with you! I believe you make sense with what you said. Taurx pharamcutical a great example with how long it takes to commercialize a new drug. Have they started since 2002 for a drug slowing
...more
(571)
•••
mdjbrown
X
View Profile
View Bullboard History
Comment by
mdjbrown
on Apr 06, 2024 10:41am
RE:RE:A secret pharmaceutical partner
s1i, it is interesting that Avicanna has claimed proprietary SEDDS tech, when it appears there is SEDDS, SMEDDS, and SNEDDS tech used in several delivery system applications? https:/
...more
(571)
•••
mdjbrown
X
View Profile
View Bullboard History
Comment by
mdjbrown
on Apr 06, 2024 10:00am
RE:Our competition and somewhat good news. MEDIF update us pls.
Olaf123, if you search LiBBY, Life's End Benefits of Cannabidiol and Tetrahydrocannabinol (LiBBY) it will provide further information on this trial https://libbystudy.org/ https
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Apr 06, 2024 9:24am
RE:A secret pharmaceutical partner
SEDDS used by LABS is a new treatment method because it provides a more efficient form of absorption in the body...wait for the generic Epidiolex launch in the U.S. news from LABS. We
...more
(131)
•••
QContinuum1
X
View Profile
View Bullboard History
Comment by
QContinuum1
on Apr 06, 2024 9:15am
RE:Our competition and somewhat good news. MEDIF update us pls.
Please keep in mind that while there may well be exciting future drugs based on cannabinoids, the trial you reference is only a Phase II and has a very long way to go before commercialization; quite
...more
(29)
•••
Olaf123
X
View Profile
View Bullboard History
Comment by
Olaf123
on Apr 06, 2024 4:49am
RE:RE:RE:Our competition and somewhat good news. MEDIF update us pls.
''Last year, Rexulti (brexpiprazole) pulled in 2.85 billion Danish kroner ($405 million) in sales for Lundbeck. In mid-2022, SVB Securities analysts noted that the
...more
(29)
•••
Olaf123
X
View Profile
View Bullboard History
Comment by
Olaf123
on Apr 06, 2024 4:34am
RE:RE:Our competition and somewhat good news. MEDIF update us pls.
If this study is successful, who will commercialize the drug? '' the Company will supply the Sponsor and the Principal Investigators with the study drug and placebo, and such other
...more
(29)
•••
Olaf123
X
View Profile
View Bullboard History
Comment by
Olaf123
on Apr 06, 2024 4:22am
RE:Our competition and somewhat good news. MEDIF update us pls.
For more context: https://www.newswire.ca/news-releases/medipharm-labs-enters-cannabis-research-agreement-with-keck-school-of-medicine-of-usc-865838274.html
(100)
•••
Solid1
X
View Profile
View Bullboard History
Post by
Solid1
on Apr 06, 2024 4:21am
A secret pharmaceutical partner
As far as the generic of Epidiolex is concerned, I think it's more about the active ingredients in this drug... The GW/Jazz patents relate to the treatment of epilepsy. If the pharma partner has
...more
(29)
•••
Olaf123
X
View Profile
View Bullboard History
Post by
Olaf123
on Apr 06, 2024 4:02am
Our competition and somewhat good news. MEDIF update us pls.
IGC pharma is developing like us a drug for Alzheimer agitation disorder https://youtu.be/op8VMy43rFQ?si=y3SHC5hVLhTjSlBt&t=74 They said this is the first natural cannabis
...more
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >